4.6 Article

Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome

期刊

出版社

SPRINGER
DOI: 10.1007/s00464-012-2730-5

关键词

Adenoma; Autonomous cortisol secretion; Conservative treatment; Laparoscopic adrenalectomy; Subclinical Cushing syndrome

类别

向作者/读者索取更多资源

Subclinical Cushing syndrome in patients with adrenal incidentalomas has been associated with an increased prevalence of the metabolic syndrome and cardiovascular risk. The management of these patients, be it conservative or surgical, is still debated, but there is accumulating evidence that surgery is best and that laparoscopic adrenalectomy, when possible, is the most preferred procedure. Here we present the short- and long-term results of laparoscopic adrenalectomy for subclinical Cushing syndrome and determine the effect of this procedure on components of the metabolic syndrome. Twenty-nine patients, 8 men and 21 women with adrenal incidentalomas and subclinical Cushing syndrome who underwent laparoscopic adrenalectomy, were studied retrospectively. They had undergone postoperative follow-up for improvement or worsening of their arterial blood pressure, body weight, and fasting glucose level for a mean period of 77 months. Preoperatively, 17 patients (58.6 %) had arterial hypertension, 14 (48.3 %) had a body mass index exceeding 27 kg/m(2), and 12 (41.4 %) had diabetes mellitus. Postoperatively, a decrease in mean arterial pressure was found in 12 patients (70.6 %), a decrease in body mass index in 6 patients (42.9 %), and an improvement in glycemic control in 5 patients (41.7 %). Laparoscopic adrenalectomy is beneficial in many patients with subclinical Cushing syndrome because it reduces arterial blood pressure, body weight, and fasting glucose levels. Prospective randomized studies are needed to compare laparoscopic adrenalectomy with a conservative approach and to confirm these results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

L-Dopa Stimulates Cortisol Secretion through Adrenocorticotropic Hormone Release in Short Children

Chrisanthi Marakaki, Dimitrios T. Papadimitriou, Kleanthis Kleanthous, Anna Papadopoulou, Anastasios Papadimitriou

HORMONE RESEARCH IN PAEDIATRICS (2015)

Article Pediatrics

Early Adiposity Rebound and Premature Adrenarche

Chrisanthi Marakaki, Olga Karapanou, Alexandros Gryparis, Ze'ev Hochberg, George Chrousos, Anastasios Papadimitriou

JOURNAL OF PEDIATRICS (2017)

Article Behavioral Sciences

Increased symptoms of anxiety and depression in prepubertal girls, but not boys, with premature adrenarche: associations with serum DHEAS and daily salivary cortisol concentrations

Chrisanthi Marakaki, Panagiota Pervanidou, Ioannis Papassotiriou, George Mastorakos, Ze'ev Hochberg, George Chrousos, Anastasios Papadimitriou

STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2018)

Article Endocrinology & Metabolism

L-Dopa Is a Potent Stimulator of Cortisol in Short Children

C. Marakaki, D. T. Papadimitriou, A. Papadopoulou, A. Fretzayas, A. Papadimitriou

HORMONE RESEARCH IN PAEDIATRICS (2014)

Article Endocrinology & Metabolism

Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol

Dimitrios T. Papadimitriou, Chrisanthi Marakaki, Andreas Fretzayas, Polyxeni Nicolaidou, Anastasios Papadimitriou

JOURNAL OF DIABETES (2013)

Review Endocrinology & Metabolism

Growth variations with opposite clinical outcomes and the emerging role of IGF-1

Anastasios Papadimitriou, Chrisanthi Marakaki, Dimitrios T. Papadimitriou

Summary: Normal growth pattern variations are associated with early puberty and delayed puberty, and insulin-like growth factor-1 (IGF-1) plays a crucial role. Early activation of the growth hormone (GH)/IGF-1 axis induces the growth pattern of early puberty, and IGF-1 is a key factor for the release of the gonadotropin-releasing hormone (GnRH) inhibition brake in prepuberty.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2022)

Article Pediatrics

Secondary Prevention of Diabetes Type 1 with Oral Calcitriol and Analogs, the PRECAL Study

Dimitrios T. Papadimitriou, Eleni Dermitzaki, Panagiotis Christopoulos, Maria Papagianni, Kleanthis Kleanthous, Chrysanthi Marakaki, Anastasios Papadimitriou, George Mastorakos

Summary: Research shows that taking 2000 IU of cholecalciferol daily from birth can reduce the incidence of type 1 diabetes (T1D) by 80%. Oral calcitriol has been found to convert T1D-associated autoantibodies (T1Ab) to negative within 0.6 years. A clinical trial has shown that secondary prevention of T1D with calcitriol and its analog paricalcitol can effectively prevent the development of T1D.

CHILDREN-BASEL (2023)

Article Endocrinology & Metabolism

A Greek girl with 11β-hydroxylase deficiency due to compound heterozygosity for two novel mutations in CYP11B1 gene

Chrisanthi Marakaki, Anna Papadopoulou, Olga Karapanou, Dimitrios T. Papadimitriou, Kleanthis Kleanthous, Anastasios Papadimitriou

ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2015)

暂无数据